‘Concussion pill’ shows promise in pre-clinical pilot study

(University of Miami Miller School of Medicine) The findings of a pre-clinical pilot study testing a of combining CBD (a cannabinoid derivative of hemp) with an NMDA antagonist (an anesthetic used in animals and humans) for the treatment of traumatic brain injury and concussion. were recently released, and show that the combination therapy improved the cognitive functions of animals, compared with those treated with a single vehicle. In addition, there were no adverse effects from either the combination therapy or the individual components.